It's OK tadacip wikipedia Sarilumab is a subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor and Neil Graham, head of immunology and inflammation at Regeneron, noted that “IL-6 blockade is emerging as an important therapeutic approach for rheumatoid arthritis. Tanya Momtahen, who leads the sarilumab project at Sanofi, added that the firm was particularly encouraged by the impact sarilumab demonstrated on inhibition of progression of structural damage. 必須 2000文字以内 [bbs:youtube:(Youtubeの動画ID)]と書くとYoutubeの動画が貼れます。(例:[bbs:youtube:OQThUAQ0UN0])